Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Didn't we already have this conversation, where you explained your frustration and offered an apology to me?
Try reading this slowly- http://investorshub.advfn.com/boards/read_msg.aspx?message_id=78180958
These are opinions, and are posted here on this forum for
discussion. It is not a personal attack towards you, or anyone on this board. So, why are continuing to be hostile?
GLTY
I have to laugh. Again, I said that the gap fill is a possibilty, and that I will wait to buy to see if it can break through the next level of resistance. The stock failed to do that in it's first attempt and I stated that it may take another stab at it on Monday. My though process is based on where the stock sits now.
Others bought in at a lower PPS and have options I don't.
Hence, as far as the RSI being @ above 70, I believe I said that it may not be a good thing. As the stock can go either way due to the time frame on the release of the results and the technicals that exist.
We are speaking in English aren't we?
BTW-The strong close Armani was expecting didn't happen did it? Yet, that person now is saying that it is going to dip next week to move up to next leg. Scratching my head...
Exactly! That said, not knowing where Armani has his RSI indicator set at, it's hard to say what he is seeing. Meaning he didn't say what period he was using. Then again, I really don't think it matters, based on his blanket statement regarding an RSI of 72 being a strong sign...
Aramni-Thank you for placing me on ignore. Besides judging from your comprehension it's where not only I, but anyone that posts opinions have been.
As to being wrong or correcting myself, I believe the link on RSI, and my post will attest to the accuracy to my analysis opinion, but my intend. Which certainly wasn't as you claimed it to be-bashing. Again, I will wait for an entry whether it is at 1.60 or 1.14, which doesn't mean anything personally toward you or because you entered at 1.09, it's JMHO. Also, I stated in my post that some of us aren't sitting where you are...good for you, but I can't trade with your shares, I have to make a decision based on where things are now.
GLTY
Armani a RSI of 72 is not a good thing. Perhaps this link might be of some help-Traditionally, and according to Wilder, RSI is considered overbought when above 70
http://stockcharts.com/school/doku.php?id=chart_school:technical_indicators:relative_strength_in
Unfortunately, some are technically-challedged, and are having a bout with reading comprehension, even after I re-addressed it in an effort to clarify my analysis. As I stated, it could be a breakout gap, and not need to be filled. Either way, at the risk of repeating myself, 1.60 is the other end of that spectrum. A long term chart will reveal why the stock met resistance at 1.55. Monday it may take another stab it. I can wait...UBSS has been pressuring the ASK with larger blocks.
GLTY
I believe that is the case.
Sharing information on this or any company, is the objective, and rules on this forum. While technical analysis, diplomacy and manners are things that are learned.
GLTY
Apology accepted. FYI-I only see one gap. http://finance.yahoo.com/q/bc?s=CPRX&t=1y&l=off&z=l&q=c&c=
Get a grip. Do you understand that we are admitting to having missed the run from .50. I'll try to make this short and keep it simple. If it breaks 1.60 it could run to 1.90 or above. If it doesn't there is a gap in the charts that "MAY" need to be filled. To that point it may be a breakout gap, which may not need to be filled. Either way, because we aren't as fortunate as you and others, we need to see how things unfold.
FYI-this is suppose to be a board discussing these matters, that's to say things that pertain to the company and stock. I would hope this clarifies things for you and others.
I don't know but, I believe the poster stated in response to me that...
my opinion, today was make it break it.
If it was insiders helping inflate the price, they would only need to do it long enough to meet the NASD requirements. Since, there wasn't a sell off (which I expected). Then it seems pretty good to me. I'm not buying now, but I did miss the maximum gains.
Reading comprehension appears lacking or are you just misunderstanding the posters words?
Do you always selectively read posts? Is that what I said? Try reading it again-GLTY
Yes, it is possible, this is why I will wait at this point to see if it can break through the next resistance level, but nonetheless there is a gap at 1.14 and there is time to fill it before the phase II results are released. You perhaps are sitting in the best seat, but others at this point need to be aware of what is at hand. I would rather pay a few peenies more than to buy and have that gap come into play.
In looking at a one year chart the decent started at the 1.90 mark and once it went through 1.54 it continue downward breaking the 1.00 mark and dipping to .50's where it has always bounce off of. You can see this by pulling up a 5 year chart. It's done so three times starting in July of 09.
The recent news appears to be a shot in the arm. I am late to the party, but am looking to see if it can break through 1.60 to confirm 1.90 or better run from there.
JMHO
It was an technical observation, nothing more.
GLTY
Good morning-Not trying to pour cold water here, but there is a gap at 1.14. May have to fill to move up toward the 1.90 mark.
JMHO
Or how about this: 08-18-2010 Dr. Robert Melamede, Ph. D., Cannabis Science Inc., President & CEO said, "Importantly, unlike big pharma, Cannabis Science will be able to immediately begin using data acquired from RockBrook patients using Cannabis Science Brands to evaluate our medical marijuana prior to FDA clinical trials. We are enthusiastic that our relationship with Mr. Pasquale and RockBrook has been established under a licensing and manufacturing agreement that is compliant with the current Colorado regulatory environment. RockBrook will immediately begin marketing and developing new Cannabis Science Brand of Pharmaceutical Products."Under the terms of the Agreement RockBrook will pay Cannabis Science an initial license fee of USD $25,000, which is payable within the first year of the Agreement. As well, RockBrook will pay Cannabis Science a quarterly royalty payment of 50% of all positive revenues derived from the Cannabis Science Brand of Pharmaceutical Products. If RockBrook enters into any sublicensing agreements, Cannabis Science is entitled to royalty payments of 50% of all positive revenues received by the Licensee for sales of any Cannabis Science Brand of Pharmaceutical Products. Within 2 years of the execution of this Agreement RockBrook will invest a minimum of $250,000 in research and development directly associated with the Cannabis Science Brand of Pharmaceutical Products. RockBrook will also pay to Cannabis Science a yearly renewable license fee, payable annually on the anniversary of the execution of this Agreement, according to the following schedule; First Anniversary payment USD $25,000, Second Anniversary USD $50,000, Third Anniversary USD $75,000, Fourth Anniversary USD $100,000, Fifth and Successive Anniversaries USD $150,000. NOT A DIME IN TWO YEARS!
http://cannabisscience.com/news-a-media/press-releases/200-cbis-signs-first-licensing-agreement-with-rockbrook.html
And Europe, well, not the first time they PR'd that either. I have noted that their PR's have a pattern to them. Here they tried to bluster themselves by riding the coat-tails of GW Pharm.
August 30, 2010
COLORADO SPRINGS, Colo., (GLOBE NEWSWIRE) -- Cannabis Science Inc. (OTCBB:CBIS - News) ("Cannabis Science, CBIS, or Company"), a pioneering US biotech company developing pharmaceutical cannabis products, is pleased to announce that the Company is currently raising working capital in the European market and pursuing listings on the Frankfurt and other major European exchanges.
Cannabis Science is vigorously seeking entry into the European medical cannabis market on the footsteps of GW Pharmaceuticals plc (GWPharm.com), a UK based commercial cannabinoid pharmaceutical company, which paved the way with the introduction and approval of its product, Sativex(R) in the UK and now Spain, which gave its regulatory approval on July 28, 2010. Currently Sativex(R) is approved in the UK and Spain as a prescription medicine for treatment of MS spasticity and in Canada for relief of neuropathic pain and advanced cancer pain.
See: http://cannabisscience.com/news-a-media/press-releases/191-cbis-reprots-important-validation-for-medical-cannabis.html
Yes, ignore the use of the word immediate(ly) used by the good dr. in PR's for three years now. Dave Purdy and Mariel Selbovitz in a pic from Washington D.C.
http://www.washingtonblade.com/2012/07/12/welcoming-the-world/
Speaking of Dr.Moe-02/16/12 Press Releases Cannabis Science Appoints Former Walgreens Executive Pharmacist Dr. Moe Afaneh, Pharm D., MBA, NRCC, RNC As Chief Operating Officer (COO) To Immediately Bring The Cannabis Science Brand Of Products To The National Market
Or how about- July 17,2009-Dr. Melamede has begun negotiating with high level industry executives to build a new team with both FDA protocol and research experience to work on Cannabis Science's extensive product line up and rapid market entry initiatives.Dr. Melamede, states, "I wholeheartedly welcome the opportunity to assemble my own management team to progress the outstanding formulations we have to immediately target and immobilize critical illnesses worldwide through the FDA and other government regulated distribution channels."
http://www.cannabisscience.com/news-a-media/press-releases/83-071709-the-new-cannabis-science-president-a-ceo.html
Then yesterday-Cannabis Science Signs Exclusive Joint Venture Deal with German-based Dupetit Natural Products, GmbH to Immediately Expand New and Existing Product Lines Across Europe and Internationally
Cannabis Science’s goals to produce over the counter skin products and other consumer products are a perfect match for Dupetit and their years of experience developing over the counter hemp products. The JV will produce a variety of natural food products and many more naturally sweetened products including CannaBiscuits, lollipops, colas, lemonades, chocolates, chewing gum, mints, and many more items. Additionally, the JV will target clothing lines, perfumes, fertilizers and seed genetics, as well other exciting new developments to be announced.
What do you think; does he really mean it this time?
What about TRIMCARE?
Yeah, one other thing. Technically speaking; It didn't break through 0.054 either. Man they sure make it look like the PR's are for those pre-selected lucky ones to sell into.
Of course you did. You know when to short and when to buy. Congrats...
Yep, I liked the action on the ASK. We'll see what tomorrow brings.
The ASK is getting hit. This appears to be a little different than before. Every large block is getting taken out. Needs to run through .054 lets see what happens...
We've already discussed the reason for these PR's. It has proven to be the case today. More selling! Folks, sad as it is, CBIS did not release anything of value today. Topical application of what?
Face it, all you witnessed today is the same type of nothing this management team has been delivering for years. It's down on a news day, and what, we're still going to defend them dispite what we are witnessing?
Look most of us here know what needs to happen. Pictures of a scalp isn't prove of anything. If it were then the stock would be moving in the other direction.
Where is the TRIMCARE redrafted agreement?
Cannabis Science Releases New Photos on the Continual Improvement of Patient Three Who Suffers from Squamous Cell CarcinomaLast update: 7/30/2012 11:32:00 AMCOLORADO SPRINGS, Colo., Jul 30, 2012 (BUSINESS WIRE) -- Cannabis Science (CBIS), a pioneering U.S. Biotech Company developing pharmaceutical products for global public health challenges is pleased to report on the continued progress made by Patient Three who suffers from an extremely severe case of chemo- and radiation-resistant squamous cell carcinoma. Cannabis Science has been working closely with Patient Three for some time. He has been self-administering a topical cannabis-based extract, and continues to see reduction of the tumor mass along with apparent healing. The patient's oncologist is impressed with the improvement made from the topical application of CSSC-1. The treatment has reduced the tumor mass down to the exposed skull, as seen in the lesion on the left side of the patient's head. There has also been a significant reduction of the tumor mass on the right side of the patient's head, and the outer perimeter of the tumor itself is decreasing. The growth of new tissue is readily seen. An HIV physician with extensive oncology experience had the opportunity to view the photo-documentation from Patient 3 and commented, "How come I know nothing about this? We need to do trials now." Dr. Melamede however has noted that the healing process is taking longer now that the tumor has been significantly reduced in size. "Perhaps now that the tumor burden has been significantly reduced, surgery to close the wound might be a sensible option. We look forward hearing his oncologist's opinion after his next visit in August." The new photos of Patent 3 can be seen on the Cannabis Science website , "View Images of 3rd Self-Medicated Patient & His Apparent Success." More news on this 3rd patient, as well the other patients can be viewed on the Cannabis Science website, by clicking on the breaking news button where you will find all the cancer related and updated patient news.
Things that make one say HMMMM-Someone isn't making any sense. Claiming that a reversal has been inplay for some time. Now claim to have sold some for capital on other stocks. While hoping it doesn't move to buy some at .04 ???
Sounds a lot like CBIS PR's...
Not sure if that date matters. They usually file an NT, meaning they will be late in filing. Have to say they are consistant with regards to being late and vague. I'm sure that has to do with the powers to be as well, (smiling).
How do you suppose they tell you about it...send up smoke signals?
BTW-How's that alledge short position you claimed coming? Mathematically it was impossible, but heck it might be par for the course, as fluff appears to be in vouge...
Your comment about drama is right on. CBIS management are the ones responsible for ALL the drama. It can be read in their PR's. First the drama and euphoric accomplishments, ie; advisors, FDA alledged plans, products, acquisitions, etc, and then the drama of leaving us hanging on the lack of.
Been long for years huh? Then you must know...
Again; what does this have to do with an acquisitions that is alledged to have income-TRIMCARE? Remember they alledgely had a done deal. All that was to happen was redrafting of the agreement. Why is it that folks choose to ignore the obvious?
Over 30 days since the update and it took 10 days for them to release that there were legal problems. Yet, some believe that it was due to shareholders threatening to report them to the SEC for lack of an 8K filing. This has been their MO since 2009, yet posters continue to say they need time. Big things are going on behind close doors. They don't have doors, other than the one on the PO box where they keep the minature furniture and lab equipment. There has always been an excuse for the lack of follow through. Makes one wonder who are the folks still thinking that it's all been some sort of a misunderstanding regarding management because of unforseen circumstances.
If it's going to bounce it will have to happen here, or it will drift even lower. No one is interested in this stock. Or do you believe that buying is taking place on this stock at the moment?
Like I said, come on bring on the HUGE PR!!! I mean not we did this and oh well, no we didn't PR.
The patient stated, "As for my head... the oncologist was amazed by the progress... as the one tumor on my right side is now almost down to conforming with the natural shape of my head and he thinks the others are being killed off too but predicted it might be a couple more months before he could declare it works... Cautious optimism. Also the doctor said that he is hopeful that this works, as there is no known chemo that cures this type of cancer."
So, the patient is predicting and the oncologist is all but neutral.BTW-It's been over two months now.
Why didn't Dr.Bob comment on the estimated time the patient felt it would take to see if it will work? After all wouldn't he know best, he is the "DOCTOR" well, not really, but should know better than the patient.
The Dr. apparently needs time to do everything. Clinic, Trimcare, you name it, "time" has proven one thing for sure, and that is that time doesn't do anything except allow those that own shares between 0.001 and .03 the opportunity to sell. Some individuals have received shares worth $500000.00 for producing $25000.00 in revenues, which should not be confused with earnings. No need to go into all the other unidentified consultants that received shares that have come and gone. For these few, and management and others (Darbey) that is getting paid very well, if things don't work out they can blame it on others or something, and leave without having lost a thing. Just read the past filings.
Perhaps they should had taken their time to review agreements more carefully before hand. Then again, if it really was only fluff.
The stock continues to go lower. when the volume increases folks post that something is happening. When it's less they post that the selling has ended. Meanwhile, we read about alledged emails claiming the Dr. is promising more of the same, a PR. Thanks, but how about we stay on task.
How long does it take to redraft an agreement that is pretty cut and dry? It's not rocket science, they should know by now whether the deal is on or off. The problem is that the deals are only in PR's. Nothing, absolutely nothing has come from all the hoop-LA since 2009.
What the science of cannabis is capable of doing has nothing to do with acquisitions, especially one that according to a PR is already producing income-(TRIMCARE). Again, what about the manipulation of the facts as the second location was ready to go as a lease was signed and then when shareholders made a stink about no 8K being filed, the next PR stating that the deal had hit a wall and the second location was still be in negotiations, but that there were plans for a third, forth and fifth locations. FANTASTIC, lets get the first one done so we can move ahead on those dreams.
I will close by saying I truly hope this is all due to their lack of knowing how to run a company, not that a company exist here, since all they appear to produce are shares and PR's.
Okay, Doc let's have the next PR, it should be one filled with more creditable data, and not more of what we have received to date.
Oh there are better ones than that. Heck reversal has been going on since .14...
Yet, yesterday you claimed you were going to short it this morning.http://investorshub.advfn.com/boards/read_msg.aspx?message_id=77685163
While this post I'm responding to is older where you stated-
I am holding my 100 thousand shares just in case there is a Miracle! And only a Miracle! A pump and dump miracle at that! Financials! hahahahahaha!
Well, lets put that aside for now and do a little math on your short claim, and base it on today's best case senerio.
Let's assume you were able to short at the high of the day @ 0.057 and covered at the low of 0.052. You would need to short 600,000 shares to make $3000.00. The broker (if he existed) would require you to put up collateral to guarantee against potential losses. This would be around 2.50 per share shorted. In other words you would need $1.5 million in your account for this transaction.
REALLY!
Doc at the risk of sounding like I'm blowing my own horn, I have been posting those facts here for some time now. Some here as I stated are either here to distract with unfounded excuses,or are simply choosing to ignore them. This is evident by the dialog. That's to say when they can no longer dispute it they simply vanish or revert to double talk. Like the short interest or the efforts to state that the stock has support at .05. It's just that the volume isn't there to drive it lower, or do you suppose folks only think that happens when the stock is rising?
The reason the stock is where it is is not because of any shorting. Nonsense. If this stock was say .50, margin requirements would dictate that someone would have to have $5000 in their account to short 2000 shares (put up collateral to guarantee against potential losses) 2.50 per share. If the stock went to ZERO the profit would only be $1000. Mind you CBIS trades at .05.
HMMM-maybe that's the hold up on the revenues being reported. For goodness sakes, it accounting. How do you get paid for the sale of something if you don't know who to apply the accounts payable to? Then again, how do you get paid for something that doesn't exist?
I've been waiting for you-In a word bull-hockey. Not eveyone here is a novice regarding shorting penny stocks. Do some DD and you find the truth about the risk and the cost vs the profit to be made because of restrictions brokers require. Like Margin requirements. Not to mention shorting a stock that is FIVE CENTS and at it's lowest point. Come on folks lets stop all this nonsense about shorting. How about we just keep the topic on reality...
Like dilution, over issuance of shares, lack of follow through, no offices or labs at stated locations...Dabney getting paid and for what?
Not to mention what the charts really indicate...lower lows and lower highs. The mountain of shares that keep appearing on the ASK by the same MM's.
CBIS give us that big PR, my arms are getting tired of holding the bags...
I won't bother discussing the short-interest, as a really good fluff PR would trap anyone doing so at these levels.
It would simply be too risky. Someone would have to know what is coming or really believes that this company if full of coconuts.
CBIS formulations? I haven't seen anything have you? I heard they used a topical, but not even in their press releases do they claim it's their formulation.
Revenues: I'm not incorrect that is a matter of record filings, and as to your anticipation of it coming down the road, well that is as anyone can see not likely as they can't even get a location with a business-plan capable of generating those numbers. Even TRIMCARE revenues were far short of $6 million, and well, that hasn't happen and it's the end of July...so NO, based on facts , I'd say I'd be closer to being correct than you.
As to the rest of your comments regarding the length of time CBIS has been in (business), I use that term loosely, and their license agreement.
I say, I haven't forgotten, management might have forgotten and overstated their claims, and the agreements, well, lets just say they have been in place for some time and we haven't seen anything to indicate that they are selling anything that would account for revenues of $6 million...
The sell-off (s) have happen twice after hitting .17's. The first one was in March after a few timely press releases from February had worn off, and then more PR's in March it rose only to dip from that level once the cat was out of the bag in their 10K filing. All one need do is look at the volume and mamntum indicators to see that someone is slowly unloading shares. I wonder who is capable of doing that at this levels and turn a profit? What we are experiencing is lower lows and lower highs.
To get this back to where retail-holders are at, they are going to need the mother of all PR's...
I believe if you do proper DD you'll find that there isn't any real short interest in this stock. The stock is where it is for reasons that are obvious to those not willing to ignore that.
Besides, who would short a FIVE CENT STOCK?
I do enjoy your copy and paste links as to what might be beneficial in the science of cannabis. That's not to say that CBIS has proven anything beneficial regarding that science or to the development of this so called company. Unless one takes into consideration what they place and retract and simply do not follow through with in their press releases. This little move has happen several times now and has failed to move beyond 0.078 at best and most recent above the .06 or so level for 6 weeks. Not to mention that it has been in a spiral down trend since 4/09/12.
Despite the efforts of their fluff, unfulfilled PR's and appointing of Advisory members or consultants. The OS now sits at 650 million and may continue to increase as they have AS of 850 million. The 6 million dollars of revenue forecasted as guidance for 2012, has reach $25000.00 and it came at a cost of issuing over $500,000.00 worth of common shares. Not exactly heading the right direction.